DEADLINE:
The deadline has passed for submission of
overall Panel and Workshop proposals.
PROPOSAL LIMIT:
An individual cannot be listed as
a presenter on more than 2 submitted
proposals (panels, workshops, methodological
innovations and/or individual/late-breaking
research presentations and pharma pipeline
presentations) per year, and cannot be listed
for more than 4 total roles, i.e., chair,
co-chair, presenter, or discussant. THIS DOES
NOT INCLUDE POSTER PRESENTATIONS. An individual
may be a co-author on any number of submitted
abstracts.
SPECIAL CHARACTERS:
If you use Greek letters, they
will need to be spelled out instead of using the
character.
STEPS
FOR CHAIR SUBMISSION
STEP 1:
Panel and Workshop will submit their contact
information and the contact information for each
individual on their session (co-chair,
presenters, discussant).
STEP 2:
The overall title, overall abstract, submission
category and a minimum of two learning
objectives are to be entered or uploaded into
the submission site.
The abstract will provide a
general overview of the proposed presentation
(limited to 2500 characters, including title,
spaces, learning objectives and literature
reference). The abstract is a concise
description of the specific purpose, content,
methodology, results, and importance of the
proposed talk. Please state specific findings
to be presented and the importance of such
findings for advancing the field.
STEP 2A:
FOR WORKSHOPS ONLY,
chairs will be required to include a statement
of how the workshop will be less formal and
integrate audience discussion and interaction.
STEP 3:
Upload in Word or PDF the schedule for the
session. Please remember to leave a minimum of
20 minutes for discussion.
STEP 4:
Upload the chair’s CV/Brief Biography (Word or
PDF).
STEP 5:
Complete the COI disclosure.
STEP 6:
Proof read the abstract
submission
STEP 7:
Submit. If you have not completed all required
sections/items you will not be able to submit
your proposal. In the case of missing items, you
will be prompted to enter the missing
information. After submitting the overall
proposal, the co-chair, discussant and each of
the presenters will be prompted via email to
submit their needed information. Please note
that your session will no be finalized until all
presenters have uploaded their required session
documents.
STEPS FOR PRESENTER SUBMISSION
STEP 1:
Panel and Workshop Co-Chairs, Presenters and
Discussants will review and correct their
contact information that was inputted by the
Chair.
STEP 2:
Presenters will be asked to submit the abstract
title, abstract body, submission category and a
minimum of two learning objectives to be entered
or uploaded into the submission site.
The abstract will provide a
general overview of the proposed presentation
(limited to 2000 characters, including spaces,
learning objectives and literature reference).
The abstract is a concise description of the
specific purpose, content, methodology, results,
and importance of the proposed talk. Please
state specific findings to be presented and the
importance of such findings for advancing the
field. Literature references - Each submission
must list two relevant literature references.
Follow the
American Journal of Psychiatry
style—see:
http://ajp.psychiatryonline.org
STEP 3:
Presenters will upload a CV/Brief Biography
(Word or PDF).
STEP 4:
Co-Chairs, Presenters and
Discussants will be required to complete the COI
disclosure.
STEP 5:
Co-Chairs, Presenters and
Discussants will be asked to proof read the
abstract submission.
STEP 6:
Submit. If you have not completed all required
sections/items you will not be able to submit
your proposal. In the case of missing items, you
will be prompted to enter the missing
information.
For policy questions, please
contact the ASCP Executive Office at
615-649-3085 or
info@ascpp.org.
Presentation Guidelines for Panel
Session
Each panel is a moderately formal
1 ½ hour session.
Each panel must have a chair, a minimum of 3
speakers but no more than 4 speakers, and a
discussant. A co-chair is optional.
Presentations are solely
education based. The use of any advertising,
trade names, or product-group message
association is prohibited; this rule
will be strictly enforced.
NO
formal presentation, slides, or
other audio visuals are allowed for discussants.
Panel presenter’s AND ALL
co-authors' disclosures must appear on
the first slide of the
presentation. Slides will be reviewed in the
speaker ready room to endure compliance.
Once a panel is accepted, speaker
changes are NOT allowed unless approved by the
Program Committee Chair.
Logos (Company, Institution,
University, etc) are not permitted to
appear on meeting materials, including
presentation slides.
Timers are provided. It is the
responsibility of the chair to keep the schedule
approved by the Program Committee.
Audiovisual equipment available
for every panel: laptop, LCD projector, laser
pointer, podium, and microphone.
Presentation Guidelines for
Workshop Session
A workshop and clinical trials
methodology is a moderately formal 3 hour
session. Workshops should be structured to
incorporate audience member discussion. Chairs
are encouraged to take a break half-way through
the session.
A workshop must have a chair and a minimum of 3
speakers but no more than 8 speakers. A
discussant and co-chair is optional.
Presentations are solely
education based. The use of any advertising,
trade names, or product-group message
association is prohibited; this rule
will be strictly enforced.
NO
formal presentation, slides, or
other audio visuals are allowed for
discussants.
Workshop presenter’s AND
ALL co-authors' disclosures must appear
on the first slide of the
presentation. Slides will be reviewed in the
speaker ready room to endure compliance.
Once a workshop is accepted,
speaker changes are NOT allowed unless approved
by the Program Committee Chair.
Logos (Company, Institution,
University, etc) are not permitted to
appear on meeting materials, including
presentation slides.
Timers are provided.
It is the responsibility of the chair to keep
the schedule approved by the Program Committee.
Conflict of Interest
Your presentation, should it be accepted, is an
important part of NCDEU's educational component
and will be designated for continuing education
credit. It is the policy of the Accreditation
Council for Continuing Medical Education (ACCME)
that any individual who participates in a
continuing education activity must disclose any
financial interest or other relationships that
have occurred within the past 12 months. ACCME
considers relationships of the individual
involved in the CME activity to include
financial relationships of a spouse or partner.
Please note that the ACCME has not set a minimum
amount for relationships to be significant and
it states that inherent in any amount is the
incentive to maintain or increase the value of
the relationship. Examples of financial
interests include salary, royalty, intellectual
property rights, consulting fee, honoraria,
ownership interest (including stocks, stock
options or other ownership interest, excluding
diversified mutual funds). Examples of other
relationships include grants, research support,
medication, assessment tools, and any
relationship(s) with the manufacturer(s) of any
commercial product(s) or relationship(s) with
any organization(s) with an interest in clinical
research or training that may be discussed in
the educational presentation.
The ACCME Commercial Support Standards insist on
the separation of education from all promotional
activities, materials, and messages.
Presentations are an integral part of the
education and as such cannot have any
advertising, trade names or product-group
messages associated with them. Presenters are
required to give a balanced view of therapeutic
options. A "balanced view" means that
recommendations or emphasis must fairly
represent a reasonable and valid interpretation
of the information available on the subject and
no single product or service is over represented
in the education activity and that other equal
and competing products or services are included.
It is preferable to use generic names whenever
possible, if it is necessary to use a trade
name, then please use those of several
companies. Further, should your presentation
include discussion of any unlabeled or
investigational use of a commercial product, you
are required to disclose this to the
participants.
Submission deadline has passed.
